Loading
Latest filing published 18 Nov 2025 for Bioxytran, INC. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Michael Sheikh is a declared insider of Bioxytran, Inc (chief executive), with filings sourced from SEC (Form 4). Between 4 June 2021 and 25 October 2024, the trades on record add up to 7 filings.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 18 November 2025 with a transaction in Bioxytran, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations